Patent · US Active

D-glycero-B-D-heptose 1-phosphate (HMP) conjugates and use for targeted immune modulation

US11795190B2 · kind B2 · utility

0Cited by

1References

12Claims

0Family size

Assignees

National Research Council of Canada · CA
The Governing Council of the University of Toronto · CA

Inventors

Janelle Sauvageau · Ottawa, CA
Andrew Cox · Ottawa, CA
Xinyi Guo · North York, CA
Scott Gray-Owen · Calgary, CA

Key dates

Filing date	Dec 29, 2018
Grant date	Oct 24, 2023
Priority date	—
Expiry date	Nov 13, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Heptose-1-monophosphate-7-derivatives are modifiable immunomodulators that can be used to prepare clinically active conjugate compounds. Such conjugate compounds are useful in modulating an immune response in a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.